Research
Andrew has published over 200 research papers, articles, reviews and abstracts on aspects of clinical heart research and has edited a series of books that have become the leading guides to emergency and practical cardiology in Europe. He is invited to publish internationally and present at leading cardiology meetings.
He is Editorial Board member of Nature’s Digital Medicine and manuscript reviewer for leading journals including the British Medical Journal, Journal of the American College of Cardiology, Circulation, European Heart Journal, Heart Rhythm, Europace, Heart and the American Journal of Cardiology.
He is also a regular abstract reviewer for the European Society of Cardiology and British Cardiovascular Society’s annual congress.
Andrew’s research team are based at The Allan Lab in Jersey and work in collaboration with the cardiology team at Oxford University Hospitals and other academic centres in Europe.
For more information on this work visit this page.
Published papers in peer-reviewed journals
1. Vela LM, Crandall H, Lim T, Zhang F, Gibbs A, Mitchell AR, Condon A, Diamond LM, Zhang H, Sanchez B. IoMT-enabled stress monitoring in a virtual reality environment and at home.
IEEE Internet of Things Journal 2023
2. Funston R, Gibbs A, Diven J, Francey J, Easlea H, Murray S, Fitzpatrick M, Condon A, Mitchell AR. Comparative study of a single lead ECG in a wearable device.
Journal of Electrocardiology 2022;74:88-93
doi:10.1016/j.jelectrocard.2022.08.004
3. Hall A, Mitchell AR, Ashmore L, Holland C. Should we be screening people with diabetes for atrial fibrillation? Exploring patients’ views.
British Journal of Cardiology 2022;29:145–9
4. Gibbs A, Fitzpatrick M, Lilburn M, Easlea H, Francey J, Funston R, Diven J, Murray S, Mitchell OG, Condon A, Mitchell AR, Sanchez B, Steinhaus D. A universal, high-performance ECG signal processing engine to reduce clinical burden
Annals of Noninvasive Electrocardiology 2022;e12993
5. Hall A, Mitchell AR, Ashmore L, Holland C. Atrial fibrillation prevalence and predictors in patients with diabetes: a cross sectional screening study
British Journal of Cardiology 2022;29:21-25
6. Hall A, Mitchell AR, Ashmore L, Holland C. Quality of life among people with atrial fibrillation with and without diabetes: a comparison study.
British Journal of Cardiology 2021;28:139–43
7. Hall A, Mitchell AR, Wood L, Holland C. Effectiveness of a single lead AliveCor electrocardiogram application for the screening of atrial fibrillation: A systematic review
Medicine 2020;99:30(e21388)
doi: 10.1097/MD.0000000000021388
8. Sabar MI, Ara F, Henderson A, Ahmen O, Potter C, John I, Mitchell AR, Yanez-Munoz RJ, Kaba RA. A study to assess a novel automated electrocardiogram technology for screening for atrial fibrillation.
Pacing Clinical Electrophysiology 2019;42:1383-1389
9. MacLachlan H, Thomas R, Langtree J, Hare C, Mitchell AR. Is there a role for a local inpatient CT coronary angiography service in selected patients with acute coronary syndrome? A cohort analysis of inpatient tertiary centre referrals for invasive coronary angiography.
Open Heart 2016;3: e000389
doi:10.1136/openhrt-2015-000389
10. Mitchell AR, Hurry R, Le Page P, MacLachlan H. Pre-participation cardiovascular screening: is community screening using hand-held cardiac ultrasound feasible?
Echo Research and Practice 2015; 2(2):49-55
11. Le Page P, MacLachlan H, Anderson A, Penn LA, Moss A, Mitchell AR.The efficacy of a smartphone ECG application for cardiac screening in an unselected island population.
British Journal of Cardiology 2015;22:31-3
12. Stewart A, McNay R, Thomas R, Mitchell AR. Early aeromedical transfer after acute coronary syndromes.
Emergency Medical Journal 2011; 28(4):325-7
13. Arya A, Silberbauer J, Vrahimides J, Cheek E, Mitchell AR, Boodhoo L, Pugh P, Large L, Bordoli G, Taggu W, Lloyd G, Patel NR, Sulke AN. First time and repeat cardioversion of atrial tachyarrhythmias – a comparison of outcomes.
International Journal of Clinical Practice 2010; 64(8):1062–1068
doi: 10.1111/j.1742-1241.2009.02229.x
14. Ponnuthurai FL, van Gaal WJ, Burchell A, Mitchell AR, Wilson N, Ormerod OJ. Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography.
International Journal of Cardiology
doi:10.1016/j.ijcard.2007.07.141
15. Ponnuthurai FL, van Gaal WJ, Burchell A, Mitchell AR, Wilson N, Ormerod OJ. Single centre experience with GORE HELEX Septal Occluder for closure of PFO.
Heart, Lung and Circulation
doi:10.1016/j.hlc.2007.11.141
16. Boodhoo LE, Mitchell AR, Bordoli G, Lloyd G, Patel P, Sulke N. DC cardioversion of persistent atrial fibrillation: A comparison of two protocols.
International Journal of Cardiology 2007; 114(1): 16-21
doi:10.1016/j.ijcard.2005.11.108
17. Timperley J, Mitchell AR, Blackman DJ, Shirodaria C, Eichhöfer J, Mirza I, Mulet-Parada M, Becher H. Semi-automatic boundary detection to improve reporting of regional left ventricular function.
European Journal of Echocardiography 2006; 7: 209-216
doi:10.1016/j.euje.2005.06.002
18. Boodhoo LE, Mitchell AR, O’Connor J, Sulke N. Myocardial injury, neurohormonal activation, inflammation following internal atrial cardioversion.
International Journal of Cardiology 2005; 103:67-72
doi:10.1016/j.ijcard.2004.08.028
19. Timperley J, Mitchell AR, Thibault H, Mirza IH, Becher H. Safety of contrast dobutamine stress echocardiography: A single centre experience.
Journal of American Society of Echocardiography 2005; 18(2): 163-167
doi:10.1016/j.echo.2004.09.003
20. Mitchell AR, Warman E, Gerritse B, Schaaf K, Sulke N. The circadian variation of atrial defibrillation thresholds.
Journal of Interventional Cardiac Electrophysiology 2004; 10(1): 79-83
doi:10.1023/B:JICE.0000011489.99159.25
21. Mitchell AR, Spurrell PA, Boodhoo LE, Sulke N. The long term care of the patient with the atrial defibrillator.
American Heart Journal 2004; 147(2): 210-217
22. Boodhoo LE, Bordoli G, Mitchell AR, Lloyd G, Patel P, Sulke N. The safety and efficacy of a nurse-led cardioversion service.
Heart 2004; 90: 1443-1446
23. Boodhoo LE, Mitchell AR, Ujhelyi M, Sulke N. Improving the acceptability of the atrial defibrillator: automatic night cardioversion versus manual cardioversion with sedation (ADSAS2).
Pacing and Clinical Electrophysiology 2004; 27: 910-917
doi:10.1111/j.1540-8159.2004.00558.x
24. Mitchell AR, Spurrell PA, Gerritse B, Sulke AN. The atrial defibrillator sedation assessment study (ADSAS).
International Journal of Cardiology 2004; 96(2): 141-145
25. Mitchell AR, Spurrell PA, Boodhoo LE, Sulke AN. Psychosocial aspects of patient activated defibrillation.
Journal of Cardiovascular Electrophysiology 2003; 14: 812-816
doi:10.1046/j.1540-8167.2003.03108.x
26. Mitchell AR, Spurrell PA, Sulke AN. The circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation.
American Heart Journal 2003; 146(5): 902-907
doi:10.1016/S0002-8703(03)00405-8
27. Mitchell AR, Chalil S, Boodhoo L, Bordoli G, Patel NR, Sulke AN. The diazepam or midazolam study for external cardioversion (the DORM study).
Europace 2003; 5(4): 391-395
doi:10.1016/S1099-5129(03)00077-1
28. Spurrell PA, Mitchell AR, Kamalvand K, Sulke N. Treatment of persistent atrial fibrillation with an implantable atrial defibrillator and its effect on quality of life.
International Journal of Clinical Practice 2003; 57(1): 30-34
29. Mitchell AR, Spurrell PA, Ahmet H, Kempson S, Higson M, Sulke AN. Echocardiographic changes and predictors of arrhythmia recurrence after long-term use of the atrial defibrillator.
International Journal of Cardiology 2003; 89(1): 25-31
doi:10.1016/S0167-5273(02)00430-8
30. Spurrell PA, Mitchell AR, Kamalvand K, Higson M, Sulke N. Does sinus rhythm beget sinus rhythm? Long-term follow-up of the patient activated atrial defibrillator.
Pacing and Clinical Electrophysiology 2004; 27: 175-181
doi:10.1111/j.1540-8159.2004.00407.x
31. Sulke N, Spurrell PA, Kamalvand K, Mitchell AR, Higson M, Gill J, Paul V. The effect of endocardial defibrillator shocks on basic atrial electrophysiology in man.
Europace 2003; 5(1): 33-37
32. Mitchell AR, Spurrell PA, Kamalvand K, Higson M, Shanmuganathan R, Patel N, Sulke N. What is the optimal electrode configuration for atrial defibrillators in man?
Europace 2002; 3: 41-44
33. Mitchell AR, Spurrell PA, Cheatle L, Sulke AN. The effect of atrial anti-tachycardia pacing therapies in patients with the atrial defibrillator: a randomised study comparing sub-threshold and nominal pacing outputs.
Heart 2002; 87(5): 433-437
34. Mitchell AR, Patel NR, Kamalvand K, Topham A, Paul VE, Sulke N. Safety, effectiveness and cost efficacy of diagnostic electrophysiology and radiofrequency ablation in a district general hospital.
International Journal of Clinical Practice 2001; 55(5): 305-308
35. Ranaboldo CJ, Mitchell AR, Royle G, Theaker G, Taylor I. Axillary nodal status in women with screen detected breast cancer.
European Journal of Surgical Oncology 1993; 19: 130-133
Books and chapters
36. Editor. The handbook of cardiac catheterization and coronary intervention, second edition
Mitchell AR, De Maria G, Banning AP (eds.).
Oxford University Press, Oxford 2020. ISBN: 0198705646
37. Newton JD, Mitchell AR, Banning AP. Echocardiography. Oxford Textbook of Medicine 6th Edition.
Firth JD, Conlon C, Cox TM (eds).
Oxford University Press, Oxford 2020. ISBN: 0198746695
38. Newton JD, Mitchell AR, Banning AP. Acute aortic syndromes. Oxford Textbook of Medicine 6th Edition.
Firth JD, Conlon C, Cox TM (eds).
Oxford University Press, Oxford 2020. ISBN: 0198746695
39. Editor. The handbook of pacemakers and implantable cardioverter defibrillators, second edition.
Timperley J, Leeson CPM, Mitchell ARJ, Betts T (eds.).
Oxford University Press, Oxford 2019 ISBN: 0199687838
40. Richardson E, Hall A, Mitchell AR. Screening for atrial fibrillation and the role of digital health technologies.
41. Mitchell AR, Newton JD, Banning AP. Acute aortic syndromes. Oxford Textbook of Medicine: Cardiovascular Disorders Warrell DA, Cox TM, Firth JD, Dwight J (eds).
Oxford University Press, Oxford 2016 ISBN: 9780198717027
42. Mitchell AR, Newton JD, Banning AP. Echocardiography. Oxford Textbook of Medicine: Cardiovascular Disorders Warrell DA, Cox TM, Firth JD, Dwight J (eds).
Oxford University Press, Oxford 2016 ISBN: 9780198717027
43. Editor. The handbook of echocardiography, Second Edition Leeson CPM, Augustine D, Mitchell ARJ, Becher H (eds.).
Oxford University Press, Oxford 2012 ISBN: 9780199215751
44. Mitchell ARJ, Banning AP. Echocardiography. Oxford Textbook of Medicine 5th Edition.
Warrell DA, Cox TM, Firth JD, Benz EJ (eds).
Oxford University Press, Oxford 2009 ISBN: 0199204853
45. Mitchell ARJ, Banning AP. Thoracic aortic dissection. Oxford Textbook of Medicine 5th Edition.
Warrell DA, Cox TM, Firth JD, Benz EJ (eds).
Oxford University Press, Oxford 2009 ISBN: 0199204853
46. Editor. Emergencies in Cardiology (US edition). Myerson SG, Choudhury RP, Mitchell ARJ (eds).
Oxford University Press, Oxford 2010 ISBN: 0195383656
47. Mitchell AR, Asrress KN. Imaging in arrhythmia. In: Cardiovascular Imaging
Oxford University Press, Oxford 2010 ISBN: 0199568456
48. Mitchell AR, Asrress KN. Imaging in aortic disease. In: Cardiovascular Imaging
Oxford University Press, Oxford 2010 ISBN: 0199568456
49. Editor. Emergencies in Cardiology, Second Edition. Myerson SG, Choudhury RP, Mitchell ARJ (eds).
Oxford University Press, Oxford 2009 ISBN: 0199554382
50. Editor. The handbook of cardiac catheterisation and coronary intervention. Mitchell ARJ, West NJ, Leeson CPM, Banning AP (eds.).
Oxford University Press, Oxford 2008 ISBN: 9780199295791
51. Editor. The handbook of echocardiography. Leeson CPM, Mitchell ARJ, Becher H (eds.).
Oxford University Press, Oxford 2007 ISBN: 9780199215751
52. Editor. The handbook of pacemakers and implantable cardioverter defibrillators. Timperley J, Leeson CPM, Mitchell ARJ, Betts T (eds.).
Oxford University Press, Oxford 2007 ISBN: 9780198571322
53. Editor. Emergencies in Cardiology. Myerson SG, Choudhury RP, Mitchell ARJ (eds).
Oxford University Press, Oxford 2005 ISBN: 9780198569596
54. Cardiology Editor. Clinical problems in general medicine and surgery. Barker J, Devitt P, Hamilton-Craig C & Mitchell J (eds).
Elsevier Science, Edinburgh 2003 ISBN: 9780443073236
Published Abstracts
55. Brown C, Gibbs, A, Mitchell AR. Virtual reality: a new addition to the anxiolytic armamentarium during implantation of cardiac devices.
European Journal of Arrhythmia & Electrophysiology 2022;8(Supp 1):70
56. Deery A, Lilburn M, McKenna S, Fitzpatrick M, Funston R, Condon A, Mitchell AR. Accurate detection of acute psychological stress events using single lead ECG data.
57. Brown C, Jones A, Le Page P, Mitchell AR. Challenging arrhythmias in eosinophilic granulomatosis with polyangiitis.
European Society of Cardiology Congress 2022
58. Kennedy A, Mitchell AR. The effect of automated R-wave annotation on heart rate variability analysis.
Journal of Electrocardiology 2019; 57: S123-S124
doi:10.1016/j.jelectrocard.2019.11.031
59. Crockford C, Mitchell AR, Kaba R, Rudland S, Fay M, Nangalia V. SAFE2SCREEN – can patient initiated kiosk-based self- screening provide an opportunity to identify atrial fibrillation within a GP waiting room environment?
Europace 2017; 19(suppl 1): i5
doi:10.1093/europace/eux283.022
60. Crockford C, Mitchell AR, Kaba R, Rudland S, Fay M, Nangalia V. Can patient self- screening provide an opportunity to identify AF within a general practice waiting room?
Journal of the International Society for Telemedicine and eHealth 2017; 5(eS2): 29
61. Mitchell AR, Le Page P, MacLachlan H, Anderson L, Penn P, Moss A. The efficacy of a smartphone electrocardiogram application for cardiac screening in 1% of an unselected island population. World Congress in Cardiac Electrophysiology and Cardiac Techniques 2014
Europace 2014 16 (suppl 2): ii39
62. Le Page P, Mitchell AR, MacLachlan H, Hurry RW The efficacy of hand held echocardiography for community based pre-participation screening. Euroecho 2013. European Heart Journal Cardiovascular Imaging 2013;14 (suppl 2): ii145-ii172. doi: 10.1093/ehjci/jet205
European Heart Journal Cardiovascular Imaging 2013;14 (suppl 2): ii145-ii172.
63. Cooper R, Eade E, Mitchell AR. Non-invasive investigations or chest pain: The impact of national guidance on service provision and patient outcome in a district general hospital.
American Heart Association Scientific Sessions 2011.
Circulation 2011; 124: A15649
64. Asrress KN, Wilson N, Ormerod OJ, Mitchell AR. The effect of interatrial septal defect closure on migraine burden – five-year single centre experience.
British Cardiovascular Society 2009.
Heart 2009; 95(Suppl 1): A23
65. Asrress KN, Wilson N, Ormerod OJ, Mitchell AR. The effect of interatrial septal defect closure on migraine burden – five-year single centre experience.
European Society of Cardiology Conference 2009.
European Heart Journal 2009; 30(1): 2368
66. Asrress KN, Schrale RG, Mankia KS, Raza S, Puli C, Wilson N, Ormerod OJ, Mitchell AR. Prospective comparison of intracardiac versus transoesophageal echocardiography guided closure of patent foramen ovale and atrial septal defects in adults – five year single centre experience.
American Heart Association Scientific Sessions 2008.
Circulation 2008; 118: S_930
67. Asrress KN, Puli C, Raza S, Schrale RG, Wilson N, Ormerod OJ, Mitchell AR. Comparison of intracardiac versus transoesophageal echocardiography for percutaneous closure of patent foramen ovale and atrial septal defects in adults – a three year, single centre experience.
European Society of Cardiology Conference 2008.
European Heart Journal 2008; 29(1): 818
68. Leeson P, Raza S, Rayner J, Puli C, Timperley J, Mitchell AR, Becher H. Conscious sedation for transoesophageal echocardiography (TOE): Impact on procedure and patient of titrated low dose sedation. British Society of Echocardiography 2006
European Journal of Echocardiography 2007; 8(3): s33-s34
doi:10.1016/j.euje.2007.03.017
69. Boodhoo LE, Mitchell AR, Arvanitakis S, Lloyd GW, Patel N, O’Nunain S, Kamalvand K, Sulke N. The impact of atrial antitachycardia pacing on quality of life in paroxysmal atrial fibrillation.
Heart Rhythm Society 2006
Heart Rhythm 2006; 3(5): S14-15
70. Silberbauer J, Arya A, Boodhoo L, Mitchell AR, Hildick-Smith D, O-Nunain S, Kamalvand K, Lloyd GW, Patel NR, Paul V, Sulke N. Determinants of early recurrence of atrial fibrillation in pacemaker AF suppression study patient.
British Cardiac Society 2005
Heart 2005; 91(Suppl I): A9
71. Boodhoo LE, Mitchell AR, Arvanitakis S, Lloyd GW, Patel N, O’Nunain S, Kamalvand K, Sulke N. Atrial antitachycardia pacing is most effective at night.
Heart Rhythm Society 2005
Heart Rhythm 2005; 2(1): S17
72. Boodhoo LE, Mitchell AR, Kempson S, Arvanitakis S, Taylor C, Dunham D, Mohammed S, Patel N, O’Nunain S, Kamalvand K, Sulke N. Pacemaker treatment therapies for paroxysmal atrial fibrillation (the TREAT study).
Europace 2005
Europace Supplements 2005; 7: 175
73. Boodhoo LE, Mitchell AR, Kempson S, Arvanitakis S, Taylor C, Dunham D, Mohammed S, Patel N, O’Nunain S, Kamalvand K, Sulke N. Atrial antitachycardia pacing is most effective at night.
Europace 2005
Europace Supplements 2005; 7: 152
74. Haworth MJ, Mitchell AR, Gardner MA, Ormerod OJ. Reduction in attenuation artefact during myocardial perfusion scintigraphy with the use of breast tissue strapping.
7th International Conference of Nuclear Cardiology 2005
Journal of Nuclear Cardiology 2005; 12(2): S12
75. Boodhoo LE, Mitchell AR, Bordoli G, Lloyd G, Patel N, Sulke N. Initial energy selection for external DC cardioversion: Effects on efficacy, energy requirement and use of sedation.
American College of Cardiology Scientific Sessions 2004
Journal of the American College of Cardiology 2004; 43(5 Suppl A): 135A
76. Boodhoo LE, Mitchell AR, Kempson S, Arvanitakis S, Taylor C, O’Kane P, Jolieffe A, Baker S, Patel NR, O’ Nunain S, Hildick-Smith D, Paul V, Kamalvand K, Sulke N. Onset mechanisms of paroxysmal atrial fibrillation in pacemaker patients.
Cardiostim 2004
Europace Supplements 2004; 6(Suppl 1): 181
77. Boodhoo LE, Mitchell AR, Kempson S, Arvanitakis S, Taylor C, Dunham D, Patel NR, O’ Nunain S, Kamalvand K, Sulke N. The temporal distribution of arrhythmia onset patterns in patients with paroxysmal atrial fibrillation.
Cardiostim 2004 Europace Supplements 2004; 6(Suppl 1): 69
78. Boodhoo LE, Bordoli G, Mitchell AR, Lloyd G, Sulke N, and Patel NR. The safety and efficacy of a nurse led cardioversion service under sedation.
Cardiostim 2004
Europace Supplements 2004; 6(Suppl 1): 181
79. Boodhoo LE, Mitchell AR, Bordoli G, Lloyd GW, Patel NR, Sulke N. The efficacy, tolerability and sedation requirement of a high initial energy for external DC cardioversion.
Cardiostim 2004
Europace Supplements 2004; 6(Suppl 1): 64
80. Boodhoo LE, Mitchell AR, Arvanitakis S, Patel NR, O’Nunain S, Kamalvand K, Sulke N. The effect of antitachycardia pacing on symptomatic and asymptomatic arrhythmias in pacemaker patients.
Cardiostim 2004
Europace Supplements 2004; 6(Suppl 1): 74
81. Boodhoo LE, Mitchell AR, Arvanitakis S, Mohammed S, Patel NR, O’ Nunain S, Kamalvand K, Sulke N. The temporal distribution of arrhythmia onsets and termination therapy efficacy in patients with paroxysmal atrial fibrillation.
European Society of Cardiology Conference 2004.
European Heart Journal 2004; 25: 67
82. Timperley J, Mitchell AR, Thibault H, Becher H. Safety of contrast agents during dobutamine stress echocardiography: a single centre experience.
EuroEcho 2004
European Journal of Echocardiography 2004; 5(Supp 1): S111
83. Boodhoo LE, Mitchell AR, O’Connor J, Lloyd G, Sulke N. Evaluation of myocardial injury, neurohormonal activation, inflammation and ventricular dysfunction following internal atrial defibrillation.
World Pacing Congress 2003
Pacing and Clinical Electrophysiology 2003; 26(2 part II): S94
84. Boodhoo LE, Mitchell AR, Ujhelyi M, Lloyd G, Sulke N. Automatic versus manual shocks – which do patients with atrial defibrillators prefer?
Pacing Congress 2003
Pacing and Clinical Electrophysiology 2003; 26(2 part II): S95
85. Boodhoo LE, Mitchell AR, Ujhelyi M, Lloyd G, Sulke N. Improving the acceptability of the atrial defibrillator: Automatic nocturnal shock vs. manual cardioversion under sedation.
British Cardiac Society 2003
Heart 2003; 89(Suppl I): A19
86. Boodhoo LE, Mitchell AR, Kempson S, Mohammed S, Patel N, Sulke N. Pacemaker treatment therapies for drug-refractory paroxysmal atrial fibrillation (the TREAT study).
British Cardiac Society 2003
Heart 2003; 89(Suppl I): A19-20
87. Mitchell AR, Warman E, Schaaf K, Sulke N. The circadian variation of atrial defibrillation thresholds. American College of Cardiology Scientific Sessions 2003
Journal of the American College of Cardiology 2003; 41(6 Suppl A): 116A-117A
88. Boodhoo LE, Mitchell AR, O’Connor J, Lloyd G, Sulke N. Evaluation of myocardial injury, neurohormonal activation, inflammation and ventricular dysfunction following internal atrial cardioversion NASPE 2003
Pacing and Clinical Electrophysiology 2003; 26(4 part II): 1056
89. Boodhoo LE, Mitchell AR, Kempson S, Mohammed S, Patel N, Sulke N. Pacemaker termination therapies for drug-refractory paroxysmal atrial fibrillation (the TREAT study).
NASPE 2003
Pacing and Clinical Electrophysiology 2003; 26(4 part II): 1079
90. Boodhoo LE, Mitchell AR, O’Connor J, Lloyd G, Sulke N. Evaluation of myocardial damage, neurohormonal activation, inflammation and ventricular dysfunction prior to, and following internal atrial defibrillation.
European Society of Cardiology 2003
European Heart Journal 2003; 24: 277
91. Mitchell AR, Chalil S, Bordoli G, Patel NR, Sulke AN. The diazepam or midazolam study for external cardioversion (the DORM study).
World Congress of Cardiology 2002
Journal of the American College of Cardiology 2002; 39(9 Suppl B): 78B
92. Mitchell AR, Spurrell PA, Sulke N. “The patient takes charge” – psychosocial aspects of patient-activated cardioversion at home using the atrial defibrillator.
British Cardiac Society 2002
Heart 2002; 87(Suppl II): 60-61
93. Mitchell AR, Chalil S, Bordoli G, Patel N, Sulke N The diazepam or midazolam study for external DC cardioversion (the DORM study).
NASPE 2002
Pacing and Clinical Electrophysiology 2002; 25(4 Part II): 689
94. Mitchell AR, Spurrell PA, Ahmet H, Higson M, Kempson S, Topham A, Sulke N. Structural changes and predictors of arrhythmia recurrences during long-term use of the Jewel AF atrial defibrillator.
NASPE 2002
Pacing and Clinical Electrophysiology 2002; 25(4 Part II): 633
95. Mitchell AR, Warman E, Gerritse B, Schaaf K, Sulke N. The circadian variation of atrial defibrillation thresholds.
Cardiostim 2002
Europace Supplements 2002; 3(Suppl A): 262
96. Mitchell AR, Spurrell PA, Sulke N. The effect of combined pacemaker therapies on atrial fibrillation burden.
Cardiostim 2002
Europace Supplements 2002; 3(Suppl A): 245
97. Mitchell AR, Spurrell PA, Sulke N. Spouses’ views on the use of patient-activated cardioversion at home.
Cardiostim 2002
Europace Supplements 2002; 3(Suppl A): 199
98. Mitchell AR, Spurrell PA, Sulke N. Positive and negative aspects of patient-activated cardioversion at home.
Cardiostim 2002
Europace Supplements 2002; 3(Suppl A): 173
99. Mitchell AR, Chalil S, Bordoli G, Patel N, Sulke N The diazepam or midazolam study for external DC cardioversion (the DORM study).
Cardiostim 2002
Europace Supplements 2002; 3(Suppl A): 166
100. Mitchell AR, Spurrell PA, Sulke N. Psychological effects of the use of the patient activated atrial defibrillator.
Cardiostim 2002
Europace Supplements 2002; 3(Suppl A): 34
101. Spurrell PA, Mitchell AR, Kamalvand K, Topham A, Sulke AN. Diurnal pattern of atrial fibrillation onsets determined from atrial defibrillator Holters in persistent atrial fibrillation patients.
American College of Cardiology Scientific Sessions 2001
Journal of the American College of Cardiology 2001; 37(2 Suppl A): 100A
102. Spurrell PA, Mitchell AR, Kamalvand K, Topham A, Sulke AN. The impact of atrial defibrillators on the natural history of persistent atrial fibrillation. Does sinus rhythm beget more sinus rhythm?
American College of Cardiology Scientific Sessions 2001 Journal of the American College of Cardiology 2001; 37(2 Suppl A): 95A
103. Mitchell AR, Spurrell PA, Cheatle LM, Sulke AN. The effect of anti-tachycardia pacing and high frequency burst atrial pacing in patients with spontaneous persistent atrial fibrillation.
British Cardiac Society 2001
Heart 2001; 85(Suppl 1): 47
104. Mitchell AR, Spurrell PA, Sulke AN. The atrial defibrillator sedation assessment study (ADSAS).
British Cardiac Society 2001
Heart 2001; 85(Suppl 1): 46
105. Mitchell AR, Spurrell PA, Kamalvand K, Higson M, Shanmuganathan R, Patel NR, Sulke AN. A comparison study of electrode configurations for patient activated atrial defibrillation.
Europace 2001
Europace Supplements 2001; 2(Suppl B): 46
106. Mitchell AR, Spurrell PA, Kamalvand K, Topham A, Sulke AN. Is there a difference in the characteristics of paroxysmal and persistent atrial fibrillation?
Europace 2001 Europace Supplements 2001; 2(Suppl B): 108
107. Mitchell AR, Spurrell PA, Kamalvand K, Topham A, Sulke AN. Does the use of the trial defibrillator promote the maintenance of sinus rhythm?
Europace 2001
Europace Supplements 2001; 2(Suppl B): 42
108. Mitchell AR, Spurrell PA, Cheatle L, Sulke AN. The effect of atrial pacing therapies on spontaneous persistent atrial fibrillation.
Europace 2001
Europace Supplements 2001; 2(Suppl B): 202
109. Mitchell AR, Spurrell PA, Kamalvand K, Topham A, Sulke AN. The onset patterns and mean cycle lengths of paroxysmal and persistent atrial fibrillation in patients implanted with the atrial defibrillator.
European Society of Cardiology 2001
European Heart Journal 2001; 22: 545
110. Mitchell AR, Spurrell PA, Kamalvand K, Topham A, Sulke AN. Does the atrial defibrillator reduce the burden of atrial fibrillation and promote the maintenance of sinus rhythm?
European Society of Cardiology 2001
European Heart Journal 2001; 22: 562
111. Mitchell AR, Spurrell PA, Sulke AN. The atrial defibrillator sedation assessment study.
European Society of Cardiology 2001
European Heart Journal 2001; 22: 188
112. Ranaboldo CJ, Mitchell AR, Theaker G, Royle G, Taylor I. Axillary nodal status in women with screen-detected breast cancer.
Surgical Research Society 1992
British Journal of Surgery 1992; 79(5): 455
Miscellaneous papers
113. Galgut O, Le Page P, Mitchell AR. Watch for tachycardia.
International Journal of Arrhythmia 2022;23:30
doi:10.1186/s42444-022-00081-z
114. Galgut O, Mitchell AR, Le Page P. Fusobacterium species cardiac device infective endocarditis diagnosed via molecular methods.
Clinical Infection in Practice 2022;15:100155
doi:10.1016/j.clinpr.2022.100155
115. Richardson E, Hall A, Hare, C, Le Page P, Mitchell AR. Screening for heart disease in the age of digital health technologies – who, when are how?
European Medical Journal Cardiology 2022;93
doi:10.33590/emjcardiol/22-00093
116. Hill K, Brown C, Gibbs A, Mitchell AR. Virtual reality device to improve the tolerability of lumbar puncture.
BMJ Neurology Open 2022;0:e000276
117. Mitchell AR, Gibbs A, Birge M, Richardson E. Virtual reality as a therapy adjunct during emergency pericardiocentesis.
European Heart Journal – Case Reports 2020; ytaa113
118. Ahlert D, Mitchell AR. Delayed presentation of right ventricular lead perforation following defibrillator implantation: a case report.
European Heart Journal Case Reports 2019; ytz121
119. Hall A, Mitchell AR. Introducing vernakalant into clinical practice.
Arrhythmia Electrophysiology Review 2019;8(1):70–74.
120. Hall A, Mitchell AR. Should we be targeting people with diabetes when screening for atrial fibrillation?
British Journal of Cardiology 2019;26 :48–9
121. Simpson RFG, Langtree J, Mitchell AR. Ectopic beats – how many count?
European Medical Journal 2017; 5(1): 88-92
https://www.emjreviews.com/cardiology/article/ectopic-beats-how-many-count/
122. Bevan J, Penn LA, Mitchell AR. Permanent catheter drainage system for palliation of diuretic-resistant cardiac ascites.
European Journal of Heart Failure 2016; 3: 60–62
123. Mitchell AR, MacLachlan HI, Le Page P. Deconditioning the athletic heart.
BMJ Case Reports 2013
124. Eade E, Cooper R, Mitchell AR. Digoxin – time to take the gloves off?
International Journal of Cardiology 2013:164(3): 365-367
http://dx.doi.org/10.1016/j.ijcard.2011.07.034
125. Cooper R, Eade E, Mitchell AR. Do the NICE guidelines for chest pain add up?
British Medical Journal Case Reports 2010
126. Asrress KN, Banning AP, Mitchell AR. Spontaneous coronary artery dissection.
British Medical Journal Case Reports 2010
127. Mitchell AR. Coronary calcium screening.
New England Journal of Medicine 2009;361:2490-2492
128. Newton J, Mitchell AR, Wilson W, Ormerod O. Intracardiac echocardiography for patent foramen ovale closure – justification of routine use.
JACC Cardiovasc Interventions 2009; 2(4):369
doi:10.1016/j.jcin.2009.02.005
129. Arnold JR, Timperley J, Mitchell AR, Westaby S, Ormerod O. Ventricular septal rupture following abciximab infusion.
European Journal of Echocardiography 2008;9(1): 60-62
doi:10.1016/j.euje.2006.08.015
130. Pitcher A, Schrale RG, Mitchell AR, Ormerod OJ. Percutaneous closure of an iatrogenic atrial septal defect.
European Journal of Echocardiography 2008;9(2): 294-295
doi:10.1016/j.euje.2006.09.006
131. Leeson CP, Al-Mousawi A, Timperley J, Mitchell AR, Willett K, Wilson N, Ormerod OJ. Patent foramen ovale closure before orthopaedic surgery to reduce the risk of recurrent systemic embolism.
Journal of Trauma 2007
132. Asrress K, Mitchell AR, Evan B, Westaby S, Alp N. Cardiac papillary fibroelastoma presenting with recurrent ventricular tachycardia.
Pacing and Clinical Electrophysiology 2007;30: 820-822
doi:10.1111/j.1540-8159.2007.00761.x
133. Schrale RG, Mitchell AR, Wilson N. ‘Cobra malformation’ of an Amplatzer device during percutaneous closure of a ventricular septal defect.
European Heart Journal 2007;28(6): 698
doi:10.1093/eurheartj/ehl323
134. Mitchell AR, Timperley J, Hudsmith L, Neubauer S, Bashir Y. Intracardiac echocardiography to guide myocardial biopsy of a primary cardiac tumour.
European Journal of Echocardiography 2007;8(6): 505-506
doi:10.1016/j.euje.2006.08.005
135. Leeson P, Dass S, Mitchell AR, Ryding A, Becher H. A transesophageal echocardiography study: traumatic left atrial appendage and left upper pulmonary vein dissection.
Journal of the American Society of Echocardiography 2007;20(5):e3-5.
doi:10.1016/j.echo.2006.10.019
136. Mitchell AR, Leeson P, Timperley J, Myerson SG, Becher H, Goldman J. Atrial septal endocarditis.
European Journal of Echocardiography 2007; 8(1):48-9
doi:10.1016/j.euje.2006.06.008
137. Mitchell AR. Cardioversion and sedation.
Journal of Cardiovascular Electrophysiology 2006; 17(9): E1
doi: 10.1111/j.1540-8167.2006.00551.x
138. Cheng AS, Banning AP, Mitchell AR, Neubauer S, Selvanayagam JB. Cardiac changes in systemic amyloidosis: Visualisation by magnetic resonance imaging.
International Journal of Cardiology 2006; 113(1):e21-e23
doi:10.1016/j.ijcard.2006.07.107
139. Schrale RG, Mitchell AR, Ormerod OJ. Patent foramen ovale and the risk of cryptogenic stroke.
Journal of the American College of Cardiology 2006; 48(9): 1913-1914
doi:10.1016/j.jacc.2006.08.003
140. Mitchell AR, Timperley J, Blackman DJ, Ormerod OJ. Percutaneous closure of an atrial septal defect in a patient with congenitally corrected transposition of the great arteries.
International Journal of Cardiology 2006; 112: e76-e77
141. Mitchell AR, Boodhoo LE, Sulke N. Pacemaker implantation in a patient with paroxysmal atrial fibrillation and left pneumonectomy.
International Journal of Cardiology 2006; 112: e81-e82
142. Timperley J, Mitchell AR, Brown PD, West NJ. Flecainide overdose – Support using an intra-aortic balloon pump.
BMC Emergency Medicine 2005; 5: 10
143. Timperley J, Mitchell AR, Brown P, Betts T. Changes in intrathoracic impedance from a pneumothorax. Insights from an implanted monitoring system
Pacing and Clinical Electrophysiology 2005: 28(10): 1109-1111
144. Porto I, Mitchell AR, Selvanayagam JB, Neubauer S, Banning AP. Percutaneous treatment of simultaneous aortic dissection and pericardial tamponade during coronary intervention.
International Journal of Cardiology 2005; 105: 104-107
145. MacDonald ST, Mitchell AR, Timperley J, Forfar JC. Left ventricular pseudoaneurysm and rupture.
Journal of American Society of Echocardiography 2005; 18(9): 980
146. Rajendram R, Alp NJ, Mitchell AR, Bowler IC, Forfar JC. Candidal mechanical prosthetic mitral valve endocarditis: successful medical management with caspofungin.
Clinical Infectious Diseases 2005; 40: e72-74
147. Mirza I, Mitchell AR, Timperley J. Giant descending aortic thrombus revealed by transoesophageal echocardiography.
Heart 2005; 91: 778
148. Myerson S, Mitchell AR, Banning AP. What is the role of balloon dilatation for severe aortic stenosis during pregnancy?
Journal of Heart Valve Disease 2005; 14: 147-150
149. Dawson D, Jin XY, Mitchell AR, Ormerod OJ, Becher H. Trans-thoracic diagnosis of left atrial appendage myxoma by real time 3D echocardiography.
Journal of American Society of Echocardiography 2005; 18(2): 192-193
150. Mitchell AR. Non-pharmacological methods of maintaining sinus rhythm.
Circulation 2004; 110; e61
151. Boodhoo LE, Mitchell AR, Sulke N. The clinical and electrophysiological implications of asymptomatic atrial fibrillation.
Minerva Cardioangiologica 2004; 52(6): 547-552
152. Porto I, Mitchell AR, Banning AP. Intravascular ultrasound to guide the management of intracoronary thrombus.
Cardiovascular Ultrasound 2004; 2(1): 18
153. Mitchell AR. How do atrial pacing algorithms prevent atrial fibrillation?
Journal of Arrhythmology 2004; 38: 40-48
154. Shirodaria C, Mitchell AR, Banning AP. Emergency balloon mitral valvotomy for severe mitral stenosis during pregnancy.
Heart 2004;90: 934
155. Mitchell AR, Eichhöfer J, Roberts P, Timperley J, Ormerod OJ. Echocardiographic assessment and percutaneous closure of multiple atrial septal defects.
Cardiovascular Ultrasound 2004; 2: 9
156. Eichhöfer J, Mitchell AR, Banning AP. Emergency endovascular aortic stenting for the treatment of a ruptured atherosclerotic ulcer.
Heart 2004; 90: 793
157. Timperley J, Myerson SG, Mitchell AR. Novel imaging techniques for the differentiation of a left ventricular mass.
Heart 2004; 90: 210
158. Timperley J, Mitchell AR, Becher H. Primary cardiac lymphoma.
European Journal of Echocardiography 2003; 4(4): 327-330
159. Mitchell AR, Spurrell PA, Sulke N. Atrial fibrillation storms.
International Journal of Clinical Practice 2003; 57(4): 349-350
160. Mitchell AR, Spurrell PA, Sulke N. Reducing atrial defibrillation thresholds in patients with persistent atrial fibrillation.
Journal of Cardiovascular Electrophysiology 2003; 14: 899
161. Myerson S, Mitchell AR. Mobile phones in hospitals – a more sensible and considered approach should be adopted.
British Medical Journal 2003; 326: 460-461
162. Mitchell AR, Timperley J, Banning AP. Synergistic anticoagulation and transesophageal echocardiographic surveillance for persistent left atrial appendage thrombus.
Heart 2003; 89: 1022
163. Mitchell AR, Spurrell PA, Higson M, Ahmet H, Sulke AN. Reversal of tachycardiomyopathy by the atrial defibrillator.
European Journal of Heart Failure 2002; 4(4): 485-488
164. Mitchell AR, Slade AK. “Fax Stretch”.
British Journal of Cardiology 2002; 9(1): 49
165. Mitchell AR, Mitchell JD, Johnston RT. Deglutition syncope: Case reports and diagnostic techniques.
Cardiology News 2002; 5(2): 12-14
166. Mitchell AR. Ventricular tachycardia in a pacemaker recipient. Feature EKG.
Journal of Interesting EKGs 2001; 2(8): http://www.ekgreading.com/ vol2_no8.htm
167. Mitchell AR, Sulke N. “How do we use the atrial defibrillator?”
British Journal of Cardiology 2001; 8(5): 320-322
168. Mitchell AR. Augmented valsalva manoeuvre terminates tachycardia.
Postgraduate Medicine 2001; 110(2): 64
169. Mitchell AR, Sulke N. “The patient takes charge”. Device therapy for atrial fibrillation.
Cardiology News 2000; 4(1): 6-9
170. Mitchell AR. Augmented valsalva manoeuvre in the management of supra-ventricular tachycardia.
British Journal of Cardiology 1998; 5(12): 651-652
171. Mitchell AR, Hayek LJ. Lactobacillus endocarditis.
Journal of Infection 1999; 38(3): 200-201
172. Mitchell AR, El-Shunnar KS. Infected chronic extradural haematoma.
British Journal of Accident & Emergency Medicine 1998; 15(6): 432-433
Invited articles and reviews
173. Bremner R, Gibbs, A, Mitchell AR. The era of immersive health technology.
European Medical Journal Innovations 2020;4(1):40-47
doi:10.33590/emjinnov/19-00132
174. Turning out the lights – the importance of digital health resilience.
European Heart Journal – Digital Health 2021;2(1): 165-166
175. Banerjee A, Drumright L, Mitchell AR. Can the NHS be a learning healthcare system in the age of digital technology?
BMJ Evidence-Based Medicine 2018 ePub ahead of print
doi: 10.1136/bmjebm-2018-110953
176. Ahlert D, Mitchell AR. To pace or not to pace.. pauses in neurally mediated syncope
Foundation Years Journal 2018 (in press)
177. Hall A, Simpson R, Mitchell AR. Biomarker assays for personalised stroke risk assessment in atrial fibrillation
Cardiovascular & Hematological Disorders-Drug Targets 2017;17(1):58-63
doi: 10.2174/1871529X17666170104120746
178. Langtree J, Simpson RFG, Mitchell AR. Cardiac Amyloid
Foundation Years 2016;10(8): 36-41
https://www.123doc.com/ejournals/issue/?id=128
179. Langtree J, MacLachlan HI, Mitchell AR. Sleep with the rhythm of your heart.
Journal of Sleep Medicine 2015; 2(4): 1026 (invited review)
https://www.jscimedcentral.com/SleepMedicine/sleepmedicine-2-1026.pdf
180. Mitchell AR, Le Page P. Living with the hand-held ECG.
BMJ Innovations 2015;0:1–3
doi:10.1136/bmjinnov-2014-000029
181. Mitchell AR. Approaching the empowering age if digital technology.
European Council for Cardiology Practice 2014;13:6 (invited article)
182. Thomas R, Le Page P, Mitchell AR. Atrial fibrillation – new frontiers in anticoagulation.
Cardiovascular and Haematological Disorders – Drug Targets 2014;14:45-49
(invited review)
http://www.ingentaconnect.com/content/ben/chddt/2014/00000014/00000001/art00006
183. Le Page P, MacLachlan H, Mitchell AR. Screening for inherited cardiac disorders – specific considerations.
European Council for Cardiology Practice 2013;11:24
184. Mitchell AR. Chronic congestive heart failure. Best Practice in association with the British Medical Journal and Epocrates 2013 (invited review)
http://bestpractice.bmj.com/best-practice/monograph/61.html
185. MacLachlan HI, Mitchell AR. Patient management: Acute thoracic aortic syndromes.
Foundation Years 2013; 7(6 Part 1): 14-20 (invited article)
https://www.123doc.com/ejournals/issue/?id=81
186. Mitchell AR. Is rate more important than rhythm in treating atrial fibrillation?
British Medical Journal 2009;339:b3174 (invited review)
187. Mitchell AR, Asrress KN. Intracardiac echocardiography.
Heart 2009; 95(4):327-31 (invited review)
188. Mitchell AR. Atrial fibrillation.
Foundation Years 2008; 4(3):106-111 (invited review)
doi:10.1016/j.mpfou.2008.04.001
189. Mitchell AR, Puwanarajah P, Timperley J, Becher H, Wilson N, Ormerod OJ. Into the ICE age – the emerging role of intracardiac echocardiography.
British Journal of Cardiology 2007;14: 31-36
http://www.medscape.com/viewarticle/553893
190. Mitchell AR. Atrial fibrillation.
Medicine 2006;34(7): 254-258 (invited review)
doi:10.1383/medc.2006.34.7.254
191. Mitchell AR, Timperley J, Banning AP. Acute thoracic aortic syndromes: in association with Heart and the British Medical Journal (invited review)
192. Ashar V, Porto I, Mitchell AR. Pharmacological management of no re-flow during coronary vascular intervention.
Current Vascular Pharmacology 2006;4(2): 95-100 (invited review)
http://www.medscape.com/viewarticle/579387
193. Mitchell AR. Is this the end of the anticoagulation clinic for patients with atrial fibrillation?
Current Drug Targets – Cardiovascular and Haematological Disorders 2005; 5(5): 405-408 (invited review)
doi:10.2174/156800605774370344
194. Becher H, Lofiego C, Mitchell AR, Timperley J. Current indications for contrast echocardiography.
European Journal of Echocardiography 2005; 6(suppl 2): S1-5 (invited review)
http://dx.doi.org/10.1016/S1525-2167(05)80722-X
195. Mitchell AR, Sulke N. How do atrial pacing algorithms prevent atrial fibrillation?
Europace 2004; 6(4): 351-362 (invited review)
http://dx.doi.org/10.1016/j.eupc.2004.03.005
196. Mitchell AR. The role of pacemaker and defibrillator therapy for the treatment of atrial fibrillation.
Minerva Cardioangiologica 2004; 52(2): 141-153 (invited review)
http://www.ncbi.nlm.nih.gov/pubmed/15194995
197. Mitchell AR. “The patient takes charge” – Long term use of the atrial defibrillator.
European Heart Journal 2003; 24(23): 2075-2076 (invited editorial)
http://dx.doi.org/10.1016/j.ehj.2003.09.013
198. Mitchell AR. An update on drug therapy for the management of atrial fibrillation.
British Journal of Cardiology 2003; 10: 351-357 (invited review)
http://www.medscape.com/viewarticle/462549
199. Mitchell AR. An update on drug therapy for the management of atrial fibrillation.
British Journal of Cardiology 2003; 10: 351-357 (invited review)
http://www.medscape.com/viewarticle/462549
200. Mitchell AR, Sulke N. Does rapid atrial pacing terminate atrial fibrillation? A comparison of laboratory and device termination studies.
Cardiac Electrophysiology Review 2003; 7(4): 352-354 (invited review)
doi: 10.1023/B:CEPR.0000023137.24735.6b
201. Timperley J, Mitchell AR, Becher H. Contrast echocardiography for left ventricular opacification.
Heart 2003; 89: 1394-1397 (invited review)
202. Mitchell AR. Atrial fibrillation in the new millennium: The role of pacemaker and defibrillator therapy.
Medical Science Monitor 2002; 8(10): 233-239 (invited review)